BioCardia's CardiAMP HF Trial Echocardiography Data to be Presented at THT Meeting
ByAinvest
Tuesday, Feb 3, 2026 8:04 am ET1min read
BCDA--
BioCardia announced that echocardiography data from the CardiAMP HF trial will be presented at the Technology and Heart Failure Therapeutics (THT) Meeting. The presentation will be made by Dr. Amish Raval, a national co-principal investigator of the trial. The data is from the CardiAMP Cell Therapy for heart failure treatment and will be presented as a late-breaking clinical trial oral presentation.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet